Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low frequency of NRAS and KRAS2 gene mutations in childhood myelodysplastic syndromes.

Cancer genetics and cytogenetics - 15 Oct 2004

Jekic Biljana, Novakovic Ivana, Lukovic Ljiljana, Kuzmanovic Milos, Popovic Branka, Pastar Irena, Milasin Jelena, Bunjevacki Gordana, Bunjevacki Vera

Abstract excerpt

In children, myelodysplastic syndromes (MDS) represent less then 10% of all hematological malignancies; consequently, molecular genetic studies dealing with this group of patients are scarce. We have analyzed 35 archival bone marrow samples of children with MDS for the presence of mutations in the first and second exons of the NRAS and KRAS2 genes. Mutations were detected with single-strand conformation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to NRAS gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, ras

Share to Mutation

Share to Myelodysplastic Syndromes

Share to Polymorphism, Single-Stranded Conformational

Source

Identifiers

PMID: 15474158
DOI: 10.1016/j.cancergencyto.2004.02.025

Genes

NRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low frequency of NRAS and KRAS2 gene mutations in childhood myelodysplastic syndromes.PMID 15474158Read ↗

N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome.Semantic proximity Read ↗

NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromesSemantic proximity Read ↗

Cytogenetic analysis and RAS mutations in primary myelodysplastic syndromes.Semantic proximity Read ↗

Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML.Semantic proximity Read ↗

Isolated KRAS and NRAS mutations in adults with monocytosis and/or cytopenia(s).Semantic proximity Read ↗

NRAS mutations in de novo acute leukemia: prevalence and clinical significance.Semantic proximity Read ↗

Rare occurrence of DNMT3A mutations in myelodysplastic syndromes.Semantic proximity Read ↗

Lack of TP53 and FMS gene mutations in children with myelodysplastic syndrome.Semantic proximity Read ↗

A Pathogenic NRAS c.38G>A (p.G13D) Mutation in RARA Translocation-negative Acute Promyelocytic-like Leukemia with Concomitant Myelodysplastic Syndrome.Semantic proximity Read ↗

Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.Semantic proximity Read ↗

High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patientsSemantic proximity Read ↗

Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.